Table 3: Lipid profile before and after LDL apheresis sessions by each patient.

Pt. IDLipidsBefore LDL apheresisAfter LDL apheresis% difference
Mean ± SD/median (range)Mean ± SD/median (range)Mean ± SD/median (range)

1TC 366.6 ± 144.0196.0 (308.0–90.0)40.8 ± 12.4
TG1427.0 (5781.0–1024.0)944.5 (4462.0–497.0)35.21 (54.6–21.6)
HDL-C51.3 ± 10.546.9 ± 16.212.5 (30.2–(−23.6))

2TC 395.5 ± 95.5288.5 (364.0–213.0)28.2 ± 9.7
TG3137.5 (3888.0–2387.0)2070.0 (2753.0–1387.0)35.54 (41.9–29.2)
HDL-C37.0 ± 2.827.5 ± 4.924.95 (38.5–11.4)

3TC 492.0 ± 167.8355.0 (770.0–162.0)20.7 ± 17.7
TG3238.0 (7792.0–1200.0)2375.0 (5976.0–488.0)24.36 (85.3–1.6)
HDL-C40.6 ± 17.133.1 ± 15.428.0 (66.67–(−127.27))

4TC 212.04 ± 27.53120.0 (167.0–101.0)40.2 ± 8.9
TG1279.0 (2031.0–1015.0)773.0 (1469–100)39.3 (100.0–19.0)
HDL-C29.9 ± 4.925.3 ± 2.814.3 (30.0–6.7)

5TC 168.4 ± 31.5121.0 (205.0–75.0)26.72 ± 8.33
TG1741.0 (2537.0–1314.0)1339.0 (2057–100)25.7 (100.0–7.2)
HDL-C11.6 ± 1.910.0 ± 1.711.11 (27.3–(−7.7))

All data are expressed as mg/dL, mean ± SD/median (range). The mean data are based on multiple measurements ( = 102, only sessions, which had all three parameters, TC, TG, HDL-C, measured, were involved) during all the followup period. All values were significantly decreased < 0.001. To convert cholesterol values (TC, HDL-C) from mg/dL to mmol/L, multiply by 0.0259 and, for TGs, multiply by 0.0113. Pt. ID indicates patient identification; TG indicates triglycerides; HDL-C indicates high density lipoprotein cholesterol.